MSB to dispute FDA finding in Type A meeting, page-435

Just found this on line regarding treatment of moderate to severe Covid ARDS with steroids

"With a press releaseon June 16, 2020, reporting the results of the UK-based RECOVERY trial, theexisting approach for treating and studying patients with COVID-19 underwent amajor change. In this large open-label randomized trial enrolling 6425 patients(2104 randomized to receive dexamethasone and 4321 randomized to receive usualcare), treatment with dexamethasone (6 mg/d for 10 days) reduced mortality byone-third in patients receiving mechanical ventilation (29.3% vs 41.4%,respectively; rate ratio, 0.64 [95% CI, 0.51-0.81]) and by one-fifth inpatients receiving supplemental oxygen (23.3% vs 26.2%, respectively; 0.82 [95%CI, 0.72-0.94]) compared with usual care alone"


In interested in feedback from learned posters as to our Covid ARDS trial Primary End Pint of all cause mortality at 30 days?

Fred Grossmann has consistently referred to ventilator mortality of 60%